Complete Filing Data
NovaBridge Biosciences reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $68.26 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NovaBridge Biosciences did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $632.0K | -$1.6M | $13.8M | $1.54B | $30.0M | $53.8M | $11.6M | ||
| Research And Development Expense | $21.8M | $21.4M | $22.5M | $1.21B | $984.7M | $840.4M | $426.0M | $267.1M | $43.6M |
| Other Nonoperating Income Expense | -$4.7M | -$8.1M | -$28.3M | $83.2M | $412.9M | -$20.2M | -$16.8M | $1.5M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.8M | $5.6M | $5.6M | -$135.7M | -$120.9M | $10.7M | $53.7M | $5.9M | |
| Net Income Loss | -$22.2M | -$207.7M | -$371.1M | -$2.33B | $470.9M | -$1.45B | -$402.8M | -$298.2M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$49.7M | -$82.2M | -$141.1M | -$2.33B | $483.1M | -$1.45B | -$401.1M | -$298.2M | |
| Income Loss From Continuing Operations | -$49.7M | -$82.2M | -$141.2M | -$2.07B | $155.6M | -$1.46B | -$438.6M | -$281.0M | |
| General And Administrative Expense | $29.7M | $28.2M | $29.0M | $899.9M | $402.4M | $654.6M | $66.4M | $25.4M | |
| Comprehensive Income Net Of Tax | -$28.6M | -$202.1M | -$365.5M | -$2.47B | $350.0M | -$1.44B | -$349.1M | -$292.3M | |
| Net Income Loss Available To Common Stockholders Basic | -$1.47B | -$2.51B | -$2.33B | $470.9M | -$1.49B | -$402.8M | -$298.2M | ||
| Interest Expense | $722.0K | $9.0K | $0.00 | $957.0K | $3.0M | $11.7M | $5.6M | ||
| Income Tax Expense Benefit | $0.00 | $0.00 | $103.0K | -$3.2M | $12.2M | $0.00 | $1.7M | ||
| Income Loss From Equity Method Investments | -$1.0M | -$11.4M | -$64.7M | -$367.9M | -$108.6M | $0.00 | |||
| Amortization Of Intangible Assets | $110.0K | $778.0K | $778.0K | $1.6M | |||||
| Cost Of Revenue | $27.2M | $46.4M | $0.00 | $0.00 | |||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.27 | -$0.43 | -$0.74 | ||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.27 | -$0.43 | -$0.74 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $68.3M | $310.7M | $475.4M | $552.7M | $4.76B | $1.19B | $1.68B | $412.7M | $64.1M |
| Stockholders Equity | $201.2M | $242.6M | $417.8M | $715.1M | $5.63B | -$2.03B | -$955.1M | -$299.8M | -$14.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$242.4M | -$164.7M | -$77.3M | -$1.24B | $3.57B | -$487.6M | $1.27B | $348.6M | |
| Operating Lease Right Of Use Asset | $3.6M | $3.8M | $63.1M | $112.8M | $15.0M | $16.4M | $13.1M | ||
| Operating Lease Payments | $805.0K | $739.0K | $909.0K | $18.7M | $8.8M | $6.2M | |||
| Cash And Cash Equivalents At Carrying Value | $68.3M | $291.5M | $342.9M | $3.52B | $4.76B | $1.14B | $1.59B | ||
| Retained Earnings Accumulated Deficit | -$1.29B | -$1.26B | -$6.86B | -$4.35B | -$2.02B | -$2.49B | -$1.01B | ||
| Property Plant And Equipment Net | $201.0K | $1.8M | $60.8M | $45.7M | $25.3M | $30.1M | $27.7M | ||
| Prepaid Expense And Other Assets Current | $3.3M | $2.5M | $80.3M | $190.8M | $195.5M | $136.0M | $89.0M | ||
| Liabilities Current | $8.5M | $58.1M | $758.2M | $624.0M | $576.1M | $588.5M | $346.2M | ||
| Liabilities And Stockholders Equity | $212.7M | $368.9M | $4.07B | $5.60B | $6.33B | $1.74B | $2.38B | ||
| Liabilities | $11.5M | $126.3M | $1.16B | $1.04B | $706.6M | $668.1M | $415.7M | ||
| Common Stock Value | $19.0K | $19.0K | $132.0K | $126.0K | $114.0K | $6.0K | $6.0K | ||
| Assets Current | $176.7M | $329.9M | $3.63B | $4.78B | $5.34B | $1.36B | $2.04B | ||
| Assets | $212.7M | $368.9M | $4.07B | $5.60B | $6.33B | $1.74B | $2.38B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $33.4M | $39.8M | $213.8M | -$186.5M | -$50.8M | $70.1M | $59.4M | ||
| Accounts Payable And Accrued Liabilities Current | $7.6M | $7.8M | $706.6M | $593.3M | $560.6M | $273.6M | $67.7M | ||
| Additional Paid In Capital Common Stock | $1.46B | $1.47B | $9.58B | $9.10B | $7.70B | $389.4M | |||
| Short Term Investments | $105.1M | $20.2M | $235.4M | $753.2M | $31.5M | $32.0M | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $282.0K | $1.4M | $9.9M | $118.4M | $7.5M | $8.6M | |||
| Operating Lease Liability Noncurrent | $3.1M | $3.3M | $32.1M | $81.8M | $5.5M | $7.5M | |||
| Operating Lease Liability Current | $816.0K | $626.0K | $24.0M | $30.7M | $8.1M | $6.8M | |||
| Gain Loss On Sale Of Property Plant Equipment | $11.0K | -$488.0K | $27.0K | -$288.0K | -$8.0K | -$79.0K | |||
| Amortization Of Right Of Use Assets And Interest Of Lease Liabilities | $28.0M | $37.7M | $19.6M | $8.8M | $5.8M | ||||
| Other Assets Noncurrent | $1.4M | $248.0K | $10.9M | $26.6M | $2.0M | $18.3M | |||
| Intangible Assets Net Excluding Goodwill | $16.6M | $118.9M | $119.7M | $120.4M | $148.8M | $148.8M | |||
| Fair Value Change Of Short Term Investments | -$221.0K | -$1.9M | -$30.4M | -$11.3M | -$703.0K | ||||
| Goodwill | $162.6M | $162.6M | $162.6M | $162.6M | $162.6M | ||||
| Repayments Of Bank Debt | $48.9M | $0.00 | $50.0M | $80.0M | $99.0M | ||||
| Other Liabilities Noncurrent | $0.00 | $106.0K | $17.0M | $14.9M | $9.0M | ||||
| Put Right Liabilities | $98.1M | $88.7M | $96.9M | $116.0M | |||||
| Fair Value Adjustments Of Put Right Liabilities | $7.9M | -$34.3M | -$16.6M | -$3.0M | |||||
| Equity Method Investments | $12.1M | $30.9M | $352.1M | $664.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$335.0K | $7.6M | $42.4M | $593.9M | $3.44B | $152.7M | $1.48B | $758.6M |
| Investing Cash Flow * | -$136.0M | $102.5M | $458.4M | -$727.2M | -$201.9M | $212.5M | $9.5M | -$157.7M |
| Operating Cash Flow * | -$52.7M | -$1.30B | -$1.10B | -$973.1M | $433.6M | -$868.0M | -$280.7M | -$252.2M |
| Share Based Compensation | -$1.9M | $10.2M | $13.1M | $608.6M | $493.5M | $366.9M | $3.5M | $7.0M |
| Payments To Acquire Property Plant And Equipment | $48.0K | $164.0K | $2.1M | $29.9M | $8.0M | $12.2M | $14.4M | $20.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.9M | -$28.0K | $1.8M | $5.2M | $58.7M | $48.8M | $76.3M | -$8.8M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$213.0K | -$35.7M | $18.3M | $152.1M | $173.7M | $188.4M | $55.6M | $408.0K |
| Increase Decrease In Operating Lease Liabilities Current | -$22.1M | -$35.7M | -$18.7M | -$8.8M | -$6.2M | |||
| Increase Decrease In Other Noncurrent Liabilities | -$106.0K | -$894.0K | $226.0K | $6.0M | $7.5M | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$128.8M | -$106.6M | $15.2M | $59.8M | -$132.0K | |||
| Increase Decrease In Deferred Liabilities | -$7.5M | $3.6M | $1.4M | $2.5M | ||||
| Increase Decrease In Contract With Customer Asset | -$4.3M | $26.4M | $227.4M | -$11.0M | $11.0M | |||
| Payments To Acquire Short Term Investments | $194.7M | $100.0M | $767.5M | $1.60B | $2.49B | $134.0M | ||
| Proceeds From Stock Options Exercised | $407.0K | $6.9M | $51.3M | $9.3M | ||||
| Proceeds From Bank Debt | $118.9M | $19.0M | $0.00 | $50.0M | $80.0M | $99.0M | ||
| Proceeds From Sale Maturity And Collections Of Investments | $109.8M | $85.0M | $764.4M | $9.48B | $2.50B | |||
| Proceeds From Sale Of Short Term Investments | $9.48B | $2.50B | $102.7M | |||||
| Payments For Repurchase Of Equity | $335.0K | $8.6M | $3.0M | $0.00 | $34.9M | |||
| Proportionate Share Of Share Based Compensation Expenses Recorded In An Equity Method Affiliate | $1.0M | $7.8M | $11.4M | $58.5M | $41.2M | |||
| Increase Decrease In Contract With Customer Liability | $17.8M | $52.6M | $224.0M | -$15.8M | $15.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-0.12 | $-1.09 | $-1.96 | $-13.35 | $3.00 | $-201.19 | $-61.70 | $-51.93 |
| Earnings Per Share Basic | $-0.12 | $-1.09 | $-1.96 | $-13.35 | $3.51 | $-201.19 | $-61.70 | $-51.93 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Diluted Shares Outstanding | 186.7M | 191.4M | 189.8M | 174.7M | 157.2M | 7.4M | 6.5M | 5.7M |
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 500.0M | 500.0M | |
| Common Stock Shares Issued | 187.5M | 185.6M | 190.9M | 183.8M | 164.9M | 8.4M | 8.4M | |
| Common Stock Shares Outstanding | 187.5M | 185.6M | 190.9M | 183.8M | 164.9M | 8.4M | 8.4M | |
| Weighted Average Number Of Shares Outstanding Basic | 186.7M | 191.4M | 189.8M | 174.7M | 134.2M | 7.4M | 6.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $7.5M | $9.3M | $5.0M | $21.3M | $24.2M | $30.6M | $4.6M | $858.0K |
| Depreciation | $261.0K | $475.0K | $206.0K | $13.8M | $12.7M | $9.8M | $6.7M | $1.6M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -$13.5M | $27.3M | $52.9M | $608.6M | $402.4M | $366.9M | $3.5M | $7.0M |
| Interest Paid Net | $704.0K | $957.0K | $3.0M | $4.9M | $1.7M | |||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | -$5.6M | -$61.4M | $14.0M |
Most recent annual filing with the SEC: April 3, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.